Frank Rimerman Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.89M Buy
14,377
+292
+2% +$87K 0.26% 65
2025
Q4
$4.65M Buy
14,085
+835
+6% +$283K 0.29% 54
2025
Q3
$4.58M Buy
13,250
+4,271
+48% +$1.29M 0.29% 54
2025
Q2
$2.8M Sell
8,979
-6,198
-41% -$2.37M 0.19% 84
2025
Q1
$7.95M Sell
15,177
-1,686
-10% -$862K 0.63% 22
2024
Q4
$8.53M Buy
16,863
+759
+5% +$431K 0.62% 22
2024
Q3
$9.42M Buy
16,104
+1,355
+9% +$766K 0.67% 22
2024
Q2
$7.51M Buy
14,749
+14,725
+61,354% +$7.22M 0.53% 24
2024
Q1
$11.9K Hold
24
﹤0.01% 168
2023
Q4
$12.6K Buy
+24
New +$12.8K ﹤0.01% 164
2022
Q2
Sell
-638
Closed -$325K 126
2022
Q1
$325K Buy
638
+14
+2% +$6.75K 0.1% 100
2021
Q4
$313K Hold
624
0.11% 96
2021
Q3
$244K Sell
624
-184
-23% -$76.2K 0.09% 98
2021
Q2
$324K Hold
808
0.13% 64
2021
Q1
$301K Hold
808
0.13% 66
2020
Q4
$283K Buy
+808
New +$271K 0.13% 74

Other funds holding UNH

Frank Rimerman Advisors's UNH Position: Q1 2026 in Review

Frank Rimerman Advisors increased its UnitedHealth (UNH) stake by 2.1% in Q1 2026, buying an estimated $87K and bringing the position to 14,377 shares worth $3.89M. The position accounts for 0.26% of the portfolio, ranked #65.

Frank Rimerman Advisors first reported a position in UNH in Q4 2020 and has held it in 16 quarters since. The position peaked at $9.42M in Q3 2024. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Frank Rimerman Advisors held 14,377 shares of UnitedHealth worth $3.89M as of Q1 2026.
  • Frank Rimerman Advisors bought 292 UnitedHealth shares in Q1 2026, an estimated $87K.
  • UnitedHealth made up 0.26% of Frank Rimerman Advisors's portfolio in Q1 2026, its #65 holding.
  • Frank Rimerman Advisors first reported a position in UnitedHealth in Q4 2020 and has held it in 16 quarters since.
  • Frank Rimerman Advisors's UnitedHealth position peaked at $9.42M in Q3 2024.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.